%0 Journal Article %T Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks %+ The University of Texas M.D. Anderson Cancer Center [Houston] %+ University Medical Center [Mainz] %+ Institut Gustave Roussy (IGR) %+ Service de dermatologie %+ Cliniques Universitaires Saint-Luc [Bruxelles] %+ Université Catholique de Louvain = Catholic University of Louvain (UCL) %+ Sun Pharmaceutical Industries, Inc. [Princeton, NJ, USA] (SPI) %+ Sun Pharmaceutical Industries [Hoofddorp, North Holland, Netherlands] (SPI - (Europe) B.V.) %+ Immunology and New Concepts in ImmunoTherapy (INCIT) %+ Service de dermatologie [Nantes] %A Migden, Michael %A Loquai, Carmen %A Robert, Caroline %A Baurain, Jean- François %A Squittieri, Nicholas %A Arntz, Ramon %A Dierlamm, Jörg %A Dréno, Brigitte %< avec comité de lecture %@ 0190-9622 %J Journal of The American Academy of Dermatology %I Elsevier %P Online ahead of print %8 2022-10 %D 2022 %R 10.1016/j.jdin.2022.08.027 %Z Life Sciences [q-bio]Journal articles %G English %2 https://inserm.hal.science/inserm-03818996/document %2 https://inserm.hal.science/inserm-03818996/file/Migden_JAAD_2022_pre-proof%20online%20publication-3.pdf %L inserm-03818996 %U https://inserm.hal.science/inserm-03818996 %~ INSERM %~ CNRS %~ UNIV-ANGERS %~ FNCLCC %~ IGR %~ INCIT %~ NANTES-UNIVERSITE %~ NANTES-UNIV %~ UFR-MEDECINE-NANTES